Q3 2024 |
58 |
$1.83B |
+$381M |
-$356M |
+$24.4M |
PLD, EQIX, EXR, WELL, SPG
|
13F-HR |
11/14/2024, 03:29 PM |
Q2 2024 |
54 |
$1.58B |
+$305M |
-$483M |
-$177M |
PLD, EQIX, WELL, DLR, SPG
|
13F-HR |
8/14/2024, 12:55 PM |
Q1 2024 |
53 |
$1.76B |
+$614M |
-$676M |
-$61.6M |
PLD, WELL, EQIX, EXR, IRM
|
13F-HR |
5/15/2024, 12:17 PM |
Q4 2023 |
53 |
$1.85B |
+$439M |
-$474M |
-$35.6M |
PLD, EQIX, WELL, EXR, KIM
|
13F-HR |
2/14/2024, 02:18 PM |
Q3 2023 |
54 |
$1.66B |
+$348M |
-$362M |
-$14.1M |
PLD, WELL, DLR, EQIX, EQR
|
13F-HR |
11/14/2023, 05:07 PM |
Q2 2023 |
54 |
$1.82B |
+$273M |
-$481M |
-$207M |
PLD, EQIX, DLR, WELL, EXR
|
13F-HR |
8/15/2023, 05:29 PM |
Q1 2023 |
53 |
$1.99B |
+$600M |
-$534M |
+$65.7M |
PLD, EQIX, WELL, EXR, AVB
|
13F-HR |
5/15/2023, 04:14 PM |
Q4 2022 |
46 |
$1.88B |
+$563M |
-$567M |
-$3.54M |
PLD, EQIX, WELL, SUI, PSA
|
13F-HR |
2/14/2023, 02:37 PM |
Q3 2022 |
50 |
$1.85B |
+$327M |
-$364M |
-$36.9M |
AVB, DRE, WELL, PSA, DLR
|
13F-HR |
11/14/2022, 04:37 PM |
Q2 2022 |
50 |
$2.13B |
+$401M |
-$413M |
-$11.6M |
DLR, PSA, AVB, WELL, DRE
|
13F-HR |
8/15/2022, 02:51 PM |
Q1 2022 |
53 |
$2.53B |
+$590M |
-$202M |
+$388M |
PSA, DLR, WELL, AVB, DRE
|
13F-HR |
5/16/2022, 01:42 PM |
Q4 2021 |
46 |
$2.23B |
+$635M |
-$841M |
-$206M |
PSA, DLR, PLD, DRE, SUI
|
13F-HR |
2/14/2022, 04:08 PM |
Q3 2021 |
54 |
$2.2B |
+$471M |
-$481M |
-$10.1M |
AVB, PSA, WELL, PLD, DRE
|
13F-HR |
11/15/2021, 02:41 PM |
Q2 2021 |
52 |
$2.2B |
+$544M |
-$313M |
+$230M |
EQIX, PSA, WELL, AVB, PLD
|
13F-HR |
8/25/2021, 03:03 PM |
Q1 2021 |
51 |
$1.77B |
+$473M |
-$721M |
-$248M |
EQIX, AVB, PLD, WELL, PSA
|
13F-HR |
5/14/2021, 01:42 PM |
Q4 2020 |
51 |
$1.88B |
+$340M |
-$360M |
-$20.1M |
PLD, DRE, WELL, UDR, INVH
|
13F-HR |
2/16/2021, 03:36 PM |
Q3 2020 |
55 |
$1.7B |
+$272M |
-$364M |
-$91.3M |
PLD, EQIX, WELL, DRE, UDR
|
13F-HR |
11/13/2020, 05:24 PM |
Q2 2020 |
58 |
$1.82B |
+$351M |
-$480M |
-$129M |
PLD, EQIX, BXP, WELL, DRE
|
13F-HR |
8/14/2020, 01:18 PM |
Q1 2020 |
50 |
$1.76B |
+$413M |
-$402M |
+$11.3M |
PLD, EQIX, CONE, BXP, DOC
|
13F-HR |
5/15/2020, 12:40 PM |
Q4 2019 |
55 |
$2.37B |
+$818M |
-$551M |
+$267M |
PLD, SPG, EQR, BXP, HPP
|
13F-HR |
2/13/2020, 01:40 PM |
Q3 2019 |
50 |
$2.13B |
+$449M |
-$719M |
-$269M |
PLD, EQR, PSA, BXP, VTR
|
13F-HR |
11/14/2019, 01:38 PM |
Q2 2019 |
54 |
$2.28B |
+$472M |
-$479M |
-$7.76M |
PLD, SPG, AVB, PSA, VTR
|
13F-HR |
8/13/2019, 04:57 PM |
Q1 2019 |
54 |
$2.3B |
+$341M |
-$261M |
+$80.6M |
SPG, PLD, AVB, EQR, WELL
|
13F-HR |
5/15/2019, 11:47 AM |
Q4 2018 |
53 |
$1.94B |
+$451M |
-$405M |
+$46M |
SPG, PLD, EQR, AVB, BXP
|
13F-HR |
2/14/2019, 12:50 PM |
Q3 2018 |
56 |
$2.17B |
+$546M |
-$455M |
+$91.7M |
SPG, PLD, AVB, BXP, EQIX
|
13F-HR |
11/14/2018, 03:54 PM |
Q2 2018 |
58 |
$2.07B |
+$468M |
-$346M |
+$122M |
SPG, AVB, WELL, BXP, PLD
|
13F-HR |
8/10/2018, 03:06 PM |
Q1 2018 |
61 |
$1.8B |
+$438M |
-$352M |
+$86.3M |
SPG, AVB, PLD, DLR, FRT
|
Restatement |
5/31/2018, 03:39 PM |
Q4 2017 |
62 |
$1.75B |
+$403M |
-$396M |
+$7.12M |
AVB, SPG, WELL, PLD, FRT
|
13F-HR |
2/14/2018, 03:21 PM |
Q3 2017 |
57 |
$1.73B |
+$527M |
-$368M |
+$159M |
PLD, AVB, WELL, SPG, FRT
|
13F-HR |
11/14/2017, 11:36 AM |
Q2 2017 |
51 |
$1.6B |
+$294M |
-$371M |
-$76.3M |
PLD, AVB, SPG, EQIX, HCP
|
13F-HR |
8/14/2017, 10:55 AM |
Q1 2017 |
54 |
$1.65B |
+$506M |
-$467M |
+$38.6M |
AVB, PLD, HCP, SPG, EQIX
|
13F-HR |
5/15/2017, 02:28 PM |
Q4 2016 |
57 |
$1.61B |
+$384M |
-$478M |
-$93.8M |
SPG, AVB, PSA, VNO, PLD
|
13F-HR |
2/7/2017, 05:10 PM |
Q3 2016 |
57 |
$1.76B |
+$461M |
-$525M |
-$63.1M |
WELL, SPG, AVB, PLD, VNO
|
13F-HR |
11/14/2016, 04:57 PM |
Q2 2016 |
58 |
$1.84B |
+$412M |
-$456M |
-$43.8M |
SPG, WELL, EQR, PSA, GGP
|
13F-HR |
8/15/2016, 03:58 PM |
Q1 2016 |
56 |
$1.81B |
+$263M |
-$2.2B |
-$1.94B |
AVB, SPG, PSA, WELL, GGP
|
Restatement |
6/16/2016, 01:44 PM |
Q4 2015 |
56 |
$3.61B |
+$873M |
-$563M |
+$310M |
AVB, WELL, SPG, PSA, VNO
|
13F-HR |
2/10/2016, 06:22 PM |
Q3 2015 |
58 |
$3.1B |
+$1.89B |
-$296M |
+$1.59B |
WELL, SPG, AVB, PSA, PLD
|
13F-HR |
11/20/2015, 12:24 PM |
Q2 2015 |
1 |
$82.1M |
$0 |
$0 |
|
VTR
|
New Holdings |
9/2/2015, 10:38 AM |
Q2 2015 |
47 |
$1.48B |
+$239M |
-$398M |
-$159M |
SPG, AVB, VTR, PLD, PSA
|
13F-HR |
8/17/2015, 12:35 PM |
Q1 2015 |
4 |
$136M |
$0 |
$0 |
|
T401PS, BRX, HME, RPAI
|
New Holdings |
5/20/2015, 08:27 AM |
Q1 2015 |
49 |
$1.8B |
+$558M |
-$438M |
+$121M |
SPG, AVB, VTR, PLD, PSA
|
13F-HR |
5/7/2015, 10:32 AM |
Q4 2014 |
55 |
$1.63B |
+$400M |
-$485M |
-$84.6M |
SPG, AVB, BXP, PSA, EQR
|
13F-HR |
2/4/2015, 01:20 PM |
Q3 2014 |
47 |
$1.51B |
+$284M |
-$319M |
-$35.3M |
SPG, EQR, PSA, AVB, BXP
|
13F-HR |
11/12/2014, 11:58 AM |
Q2 2014 |
63 |
$1.6B |
+$472M |
-$476M |
-$3.53M |
SPG, EQR, AVB, PSA, BXP
|
13F-HR |
8/14/2014, 05:27 PM |
Q1 2014 |
50 |
$1.52B |
+$329M |
-$347M |
-$17.5M |
SPG, HCN, EQR, BXP, PLD
|
13F-HR |
5/13/2014, 11:25 AM |
Q4 2013 |
57 |
$1.43B |
$0 |
$0 |
|
SPG, EQR, VTR, PSA, MAC
|
13F-HR |
2/10/2014, 01:31 PM |